Related Articles
CHANGES IN PLASMA IRON LEVELS FOLLOWING CARBOPLATIN ADMINISTRATION
Survey of chemotherapy‑induced nausea and vomiting in patients with urothelial carcinoma
PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT WITH BOTH TESTICULAR CANCER AND HEMODIALYSIS-REQUIRING KIDNEY FAILURE
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
Excision repair cross complementing-group 1: Gene expression and platinum resistance (Review) parameters in human breast cancer